Nalador injection

NALADOR 500 µg lyoph p us parentér nalador The Committee deems that the clinical benefit of NALADOR is substantial in the uterotonic treatment of atonic postpartum nalador NALADOR contient une substance active, le sulprostone, qui appartient à une famille de médicaments appelés dérivés de la prostaglandine E2 Ce médicament

nalador ◗ NALADOR is a second-line uterotonic treatment of atonic postpartum haemorrhage resistant to first-line treatment with oxytocin